![D. Walke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D. Walke
Investor Relations Contact bij
IONIS PHARMACEUTICALS, INC.
Profiel
D.
Wade Walke is the founder of Ionis Pharmaceuticals, Inc., founded in 2012, where the title held was VP-Corporate Communications & Investor Relations from 2012 to 2018.
Current jobs include Senior Vice President-Investor Relations at Ionis Pharmaceuticals, Inc. since 2023 and Vice President-Investor Relations at 23andMe, Inc. since 2021.
Former jobs include Senior Director-Investor & Media Relations Contact at Lexicon Pharmaceuticals, Inc. from 2011 to 2012 and Vice President-Investor Relations at Chrome Holding Co. from 2021 to 2022.
Education includes undergraduate studies at Brigham Young University and graduate and doctorate degrees from the University of Michigan.
Actieve functies van D. Walke
| Bedrijven | Functie | Begin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Investor Relations Contact | 01-01-2023 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Investor Relations Contact | 01-06-2021 |
Eerdere bekende functies van D. Walke
| Bedrijven | Functie | Einde |
|---|---|---|
| CHROME HOLDING CO. | Investor Relations Contact | 01-06-2022 |
| IONIS PHARMACEUTICALS, INC. | Oprichter | 01-07-2018 |
| LEXICON PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Opleiding van D. Walke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
23andMe Holding Co.
 23andMe Holding Co. BiotechnologyHealth Technology Operates as a genetic testing company | Health Technology |
